Invivo Partners
Overview
Invivo Partners is a Spanish venture capital firm specializing in early-stage investments in life sciences and deeptech sectors. The firm focuses on companies developing innovative therapeutics and medical technologies, particularly at the intersection of advanced therapies, synthetic biology, and artificial intelligence. Invivo Partners manages multiple funds, including Invivo Ventures III, targeting €100 million, and has a strong network of private and institutional investors supporting its initiatives. The firm's investment strategy emphasizes supporting startups in seed and Series A stages, with investments ranging from €500,000 to €4 million. Invivo Partners has a diverse portfolio, including companies like OneChain Immunotherapeutics, Corteria Pharmaceuticals, EsoBiotec, Neumirna Therapeutics, and Signadori Bio. These investments span various therapeutic areas, such as oncology, neurology, cardiology, and infectious diseases, reflecting the firm's commitment to advancing healthcare through cutting-edge technologies. With a team combining scientific, technical, and financial expertise, Invivo Partners aims to foster growth in the health sector and become a leading player in Europe's biotech industry. The firm's investors include major institutional entities like the European Investment Fund, Fond-ICO Global, the Catalan Finance Institute, the Valencia Institute of Finance, and the Barcelona City Council, alongside a majority of private investors. This robust backing enables Invivo Partners to support transformative projects that have the potential to revolutionize healthcare and improve patients' quality of life.
Investment Focus
- Early-stage life sciences and deeptech companies
- Innovative therapeutics and medical technologies
- Focus on advanced therapies, synthetic biology, and artificial intelligence
Portfolio Companies
Reach Invivo Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Invivo Partners
What sectors does Invivo Partners invest in?
Invivo Partners invests in Healthcare, Artificial Intelligence, Medical Devices, Diagnostics, Biotechnology and Synthetic Biology, and is based in Catalonia, Spain. Invivo Partners is listed as a venture capital in the ConnectSafely investor database.
What stage does Invivo Partners invest at?
Invivo Partners backs companies at Seed, Early Stage and Series A, writing cheques of 500K - 4M.
Which regions does Invivo Partners invest in?
Invivo Partners invests across Europe and Spain.
Who are the partners at Invivo Partners?
Team members listed for Invivo Partners include Laura Gallego (Partner) and Josep Maria (Partner at InvivoAI).
What companies has Invivo Partners invested in?
Invivo Partners's portfolio includes Neumirna Therapeutics, EsoBiotec, Corteria Pharmaceuticals, OneChain Immunotherapeutics and Signadori Bio.
How do I contact Invivo Partners?
Invivo Partners's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
